| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 01/20/2004 | CA2274621C New nitrone derivatives, their preparation method and pharmaceutical compositions comprising them |
| 01/20/2004 | CA2174104C Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 01/20/2004 | CA2116782C 1-substituted 1h-imidazo¬4,5-c|quinolin-4-amines; intermediate and pharmaceutical compositions |
| 01/15/2004 | WO2004006355A2 Charge transport compositions which are quinazoline derivatives and electronic devices made with such compositions |
| 01/15/2004 | WO2004006354A2 Polymeric charge transport compositions and electronic devices made with such compositions |
| 01/15/2004 | WO2004006352A2 Electronic devices made with electron transport and/or anti-quenching layers |
| 01/15/2004 | WO2004005407A2 Tetra-azapentamethine and use thereof for dyeing keratinous fibers |
| 01/15/2004 | WO2004005406A2 Charge transport compositions on the basis of triarylmethanes and their use in electronic devices |
| 01/15/2004 | WO2004005288A2 Charge transport compositions comprising fluorinated phenanthroline derivatives |
| 01/15/2004 | WO2004005283A1 Imidazoles, oxazoles and thiazoles with protein kinase inhibiting activities |
| 01/15/2004 | WO2004005281A1 Inhibitors of tyrosine kinases |
| 01/15/2004 | WO2004005280A1 Novel quinolinic compounds showing a feature of excited-state intramolecular proton transfer (esipt) |
| 01/15/2004 | WO2004005279A2 Substituted anthranilic amide derivatives and methods of use |
| 01/15/2004 | WO2004005265A1 Quinazoline derivatives |
| 01/15/2004 | WO2004005264A2 Imidazole compounds for the treatment of hepatitis c virus infections |
| 01/15/2004 | WO2004005262A2 New neuropeptide y y5 receptor antagonists |
| 01/15/2004 | WO2004005257A1 Secondary amino anilinic piperidines as mch1 antagonists and uses thereof |
| 01/15/2004 | WO2004005252A1 Azabicyclo derivatives as muscarinic receptor antagonists |
| 01/15/2004 | WO2004005248A1 Peptide inhibitors of smac protein binding to inhibitor of apoptosis proteins (iap) |
| 01/15/2004 | WO2004004731A1 2, 5-substituted pyrimidine derivatives as ccr-3 receptor antagonists ix |
| 01/15/2004 | WO2004004730A2 2-aminopyrazine derivatives as inhibitors of cyclin dependent kinases for the treatment of proliferative disorders |
| 01/15/2004 | WO2004004727A1 3,4-dihydroisoquinolin-1-one derivatives as inducers of apoptosis |
| 01/15/2004 | WO2004004726A1 Mchir antagonists |
| 01/15/2004 | WO2004004725A2 Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases |
| 01/15/2004 | WO2004004722A1 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related compounds as neurokinin-1(nk-1) antagonists for the treatment of emesis, depression, anxiety and cough |
| 01/15/2004 | WO2004004720A1 3-`(hetero) arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors |
| 01/15/2004 | WO2004004719A1 Liquid dosage forms of non-enterically coated acid-labile drugs |
| 01/15/2004 | WO2004004718A1 Liquid dosage forms of acid labile drugs |
| 01/15/2004 | WO2004004716A1 Naphthalimide synthesis including amonafide synthesis and pharmaceutical preparations thereof |
| 01/15/2004 | WO2004004715A2 Novel delta opioid receptor ligands |
| 01/15/2004 | WO2004004657A2 Hiv integrase inhibitors |
| 01/15/2004 | WO2004004629A2 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
| 01/15/2004 | WO2003091247A3 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 01/15/2004 | WO2003082191A3 Substituted 2,3-diphenyl pyridines |
| 01/15/2004 | WO2003070725A3 Process for preparing indolinone derivatives |
| 01/15/2004 | WO2003047520A3 SUBSTITUTED AMINO METHYL FACTOR Xa INHIBITORS |
| 01/15/2004 | US20040010159 Blends of quinone alkide and nitroxyl compounds and polymerization inhibitors |
| 01/15/2004 | US20040010151 Lansoprazole polymorphs and processes for preparation thereof |
| 01/15/2004 | US20040010149 Ligand for transition metal complex catalyst |
| 01/15/2004 | US20040010148 Antiinflammatory agents, antiallergens, antiproliferative agents, immunosuppressants, antidiabetic agents, cardiovascular disorders |
| 01/15/2004 | US20040010147 Cyclic amine compounds and pharmaceutical composition containing the same |
| 01/15/2004 | US20040010031 3-aminomaleimide derivatives used for treatment and/or prophylaxis of mood disorders, schizophrenia, neurotraumatic diseases, cancer or hair-loss. |
| 01/15/2004 | US20040010030 Novel anti-infectives |
| 01/15/2004 | US20040010029 Also benzothiophene derivatives; treating allergy, asthma, rhinitis, dermatitis, B-cell lymphomas, tumors and infections; modulating T helper cells, Th1/ Th2, and inhibiting the transcription of IL-4 |
| 01/15/2004 | US20040010027 Tumor angiogenesis and metastasis inhibition. |
| 01/15/2004 | US20040010019 Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 01/15/2004 | US20040010017 Antithrombotic agents |
| 01/15/2004 | US20040010016 Control of arthropods in animals |
| 01/15/2004 | US20040010015 Pyridoxine and pyridoxal analogues: new uses |
| 01/15/2004 | US20040010014 Novel compounds as opioid receptor modulators |
| 01/15/2004 | US20040010013 Cannabinoid receptor ligands |
| 01/15/2004 | US20040010012 Selective inhibitor of the biological activity of human osteoclast cells |
| 01/15/2004 | US20040010010 Melanocortin receptor ligands |
| 01/15/2004 | US20040010008 Piperidine derivatives useful as CCR5 antagonists |
| 01/15/2004 | US20040009998 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 01/15/2004 | US20040009991 Calcium channel antagonistic activity; especially useful as analgesics |
| 01/15/2004 | US20040009990 Especially piperidinylcarbonyl- and piperazinylcarbonyl-derivatives of indoles having oxalyl groups |
| 01/15/2004 | US20040009988 Inhibiting hepatic production of apoprotein B-100 and microsomal triglyceride transfer protein to decrease VLDL and chylomicrons production |
| 01/15/2004 | US20040009977 For use in the prophylaxis and the treatment of Picornavirus and human rotavirus infections. |
| 01/15/2004 | US20040009976 Hypoglycemic imidazoline compounds |
| 01/15/2004 | US20040009974 Pyrimidylamino- or triazinylamino- substituted pyrazoles or 1,2,3-triazoles |
| 01/15/2004 | US20040009972 Benzodiazepine inhibitors of mitochondial F1F0 ATP hydrolase and methods of inhibiting F1F0 ATP hydrolase |
| 01/15/2004 | US20040009969 Diazacycloalkanes containing a 2,5-dioxo-1H-pyrrolyl- or 4-oxo-2-thioxoimidazolidinyl- groups; treating prostate cancer, benign prostate hyperplasia, androgenetic alopecia, hirsutism and androgen-dependent acne. |
| 01/15/2004 | US20040009968 Indazole compounds useful as protein kinase inhibitors |
| 01/15/2004 | US20040009967 May contain further anticancer or immunosuppressive agents |
| 01/15/2004 | US20040009122 A formulation V-L-R where v is a vector moiety having affinity for an angiogenesis-related endothelial cell receptor, L is a linker or a bond and R is a detectable moiety (v is nonpeptidic or peptide and R is a macromolecule) |
| 01/15/2004 | US20040006834 Such as 4-(5,6-dimethoxyindolin-1-yl)-phenylamine hydrochloride; hair dyes |
| 01/15/2004 | DE10228090A1 Ausgewählte Anthranylamidpyridinamide und deren Verwendung als Arzneimittel Selected Anthranylamidpyridinamide and their use as medicaments |
| 01/15/2004 | CA2492692A1 Charge transport compositions which are quinazoline derivatives and electronic devices made with such compositions |
| 01/15/2004 | CA2492690A1 Polymeric charge transport compositions and electronic devices made with such compositions |
| 01/15/2004 | CA2492689A1 Electronic devices made with electron transport and/or anti-quenching layers |
| 01/15/2004 | CA2492688A1 Charge transport compositions comprising fluorinated phenanthroline derivatives |
| 01/15/2004 | CA2492686A1 Charge transport compositions on the basis of triarylmethanes and their use in electronic devices |
| 01/15/2004 | CA2492121A1 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
| 01/15/2004 | CA2492033A1 Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases |
| 01/15/2004 | CA2491998A1 Azabicyclo derivatives as muscarinic receptor antagonists |
| 01/15/2004 | CA2491835A1 Mch1r antagonists |
| 01/15/2004 | CA2491673A1 Naphthalimide synthesis including amonafide synthesis and pharmaceutical preparations thereof |
| 01/15/2004 | CA2491041A1 Peptide inhibitors of smac protein binding to inhibitor of apoptosis proteins (iap) |
| 01/15/2004 | CA2490470A1 Pyrazole urea neuropeptide y y5 receptor antagonists |
| 01/15/2004 | CA2490463A1 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related compounds as neurokinin-1(nk-1) antagonists for the treatment of emesis, depression, anxiety and cough |
| 01/15/2004 | CA2490148A1 2, 5-substituted pyrimidine derivatives as ccr-3 receptor antagonists ix |
| 01/15/2004 | CA2490147A1 Liquid dosage forms of non-enterically coated proton pump inhibitors |
| 01/15/2004 | CA2490145A1 Liquid dosage forms of proton pump inhibitors |
| 01/15/2004 | CA2489251A1 Quinazoline derivatives |
| 01/15/2004 | CA2489166A1 Substituted anthranilic amide derivatives and methods of use |
| 01/15/2004 | CA2485379A1 Secondary amino anilinic piperidines as mch1 antagonists and uses thereof |
| 01/14/2004 | EP1380584A1 Process for making 5-substituted pyrazoles using dithietanes |
| 01/14/2004 | EP1380581A1 Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative diseases |
| 01/14/2004 | EP1380575A1 1,2-disubstituted 1,4-dihydro-4-oxoquinoline compounds |
| 01/14/2004 | EP1380297A1 8-chloro-6, 11-dihydro-11-(4-piperidylidene)-5H-benzo[5,6]cyclo-hepta[1,2-b]pyridine oral compositions |
| 01/14/2004 | EP1379587A1 Long chain hindered amines and compositions stabilized therewith |
| 01/14/2004 | EP1379525A2 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 01/14/2004 | EP1379524A2 Chromane derivatives, process for their preparation and their use as antitumor agents |
| 01/14/2004 | EP1379523A1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists |
| 01/14/2004 | EP1379522A1 DIHYDRO-BENZO(b)(1,4)DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS I |
| 01/14/2004 | EP1379520A1 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists |
| 01/14/2004 | EP1379519A1 Pyrrolidine sulfonamides |
| 01/14/2004 | EP1379518A2 Process for purifying 6-methoxy omeprazole |
| 01/14/2004 | EP1379517A2 Abca-1 elevating compounds against coronary artery disease or atherosclerosis |